Items tagged with Medicines
Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant TB (post)
SETTING
Cancer drug helps treat TB by restoring leaky blood vessels (post)
DURHAM, N.C., 26-Apr-2018 -- Biomedical engineers have discovered an unlikely potential ally in the global fight against tuberculosis -- an FDA-approved drug originally designed to treat cancer.
TB: pharmacists develop new substance to counteract antimicrobial resistance (post)
Antimicrobial resistance is on the rise worldwide. This is becoming a problem for infectious diseases like tuberculosis as there are only a few active substances available to combat such diseases. Pharmacists at Martin Luther University Halle-Wittenberg (MLU) have now found a way to increase the efficacy of a common tuberculosis agent while, at the same time, reducing resistance to it. The research group presents its latest developments in the international journal Molecules.
Russian clinical trials market in 2012-2017 (post)
The Association of Clinical Trials Organizations published its newsletter “Russian clinical trials market in 2012-2017”. Information about HCV, HIV and TB drugs is included.
Repurposing promising cancer drugs may lead to a new approach to treating TB (post)
Promising experimental cancer chemotherapy drugs may help knock out another life-threatening disease: tuberculosis (TB). A new study published by scientists at Texas Biomedical Research Institute in San Antonio pinpoints a mechanism in regulating cell death called apoptosis that is a potential new target for helping to control the bacterial infection (Mycobacterium tuberculosis or M.tb) that causes the lung disease TB.
Novel property of a new TB drug (post)
University of Otago researchers have discovered a novel property of a new anti-tuberculosis drug which may help develop more drugs to treat the top infectious disease killer in the world.
TAG's TB Activist's Toolkits now available in Spanish (post)
In addition to the Russian translations, Spanish translations of An Activist’s Guide to Tuberculosis Diagnostic Tools and An Activist’s Guide to Tuberculosis Drugs are now also available.
Scientists develop new drug treatment for TB (post)
Scientists at The University of Manchester have developed the first non-antibiotic drug to successfully treat tuberculosis in animals.
A naturally occurring antibiotic active against drug-resistant TB (post)
A naturally occurring antibiotic called kanglemycin A is effective against Mycobacterium tuberculosis, the bacteria that cause tuberculosis, even in drug-resistant strains, according to an international team of researchers who used chemistry, molecular biology, microbiology, and X-ray crystallography to show how the compound maintains its activity. A paper describing the research appears September 20, 2018 in the journal Molecular Cell.
Fluoroquinolone and quinolone antibiotics: PRAC recommends new restrictions on use following review of disabling and potentially long-lasting side effects (post)
The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has recommended restricting the use of fluoroquinolone and quinolone antibiotics (used by mouth, injection or inhalation) following a review of disabling and potentially long-lasting side effects reported with these medicines. The review incorporated the views of patients, healthcare professionals and academics presented at EMA’s public hearing on fluoroquinolone and quinolone antibiotics in June 2018.
Page 9 of 19 · Total posts: 0
←First 8 9 10 Last→